Lymphatic transport of proteins after s.c. injection: implications of animal model selection.
about
Species differences in tumour responses to cancer chemotherapyInfluence of aggregation and route of injection on the biodistribution of mouse serum albuminSerum Cartilage Oligomeric Matrix Protein: is There a Repeated Bout Effect?Subcutaneous bioavailability of golimumab at 3 different injection sites in healthy subjects.High efficiency diffusion molecular retention tumor targeting.Anatomical, physiological, and experimental factors affecting the bioavailability of sc-administered large biotherapeuticsRecombinant human hyaluronidase PH20 (rHuPH20) facilitates subcutaneous infusions of large volumes of immunoglobulin in a swine model.Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in MacaquesMechanistic determinants of biotherapeutics absorption following SC administration.Across-Species Scaling of Monoclonal Antibody Pharmacokinetics Using a Minimal PBPK Model.Effects of hypertonic buffer composition on lymph node uptake and bioavailability of rituximab, after subcutaneous administrationA Helix-Stabilizing Linker Improves Subcutaneous Bioavailability of a Helical Peptide Independent of Linker Lipophilicity.Addition of 20-kDa PEG to Insulin Lispro Alters Absorption and Decreases Clearance in Animals.Factors influencing the use and interpretation of animal models in the development of parenteral drug delivery systemsToxico-/biokinetics of nanomaterials.Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies.Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides.ADME of monoclonal antibody biotherapeutics: knowledge gaps and emerging tools.Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide.Pharmacokinetics and absolute bioavailability of mepolizumab following administration at subcutaneous and intramuscular sites.Translational mixed-effects PKPD modelling of recombinant human growth hormone - from hypophysectomized rat to patients.Absorption, distribution, metabolism and excretion of peginesatide, a novel erythropoiesis-stimulating agent, in ratsSystemic effects in naïve mice injected with immunomodulatory lectin ArtinM.Fluorescence imaging of the lymph node uptake of proteins in mice after subcutaneous injection: molecular weight dependence.Challenges and Opportunities for the Subcutaneous Delivery of Therapeutic Proteins.PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment.
P2860
Q28080727-F8E5ED00-BE6A-454F-A7AB-F7BAA25D2D7BQ28538961-58F0F5FD-E293-4125-8FCF-14464D4B250CQ34333603-00276249-BB26-4C3C-9569-99F2B9C9CE55Q34614211-A44557FE-0BCB-44F9-BFB2-27563B6EE6B7Q34625694-8D1EF365-DCD9-499C-81EE-B5DE9CD7B98AQ35032702-67AEA895-A178-4A51-A6A4-6A18C7A1DAC7Q35580799-0BFA3383-142B-4D07-81FB-8A0F7F71B4BAQ35974961-C50EA1F9-6E1A-4577-AEC6-F0A0E695A6D8Q36065572-34D21549-8D86-48BB-A3C8-8BBDEBECEB80Q36087076-539C7540-D40F-480D-AFDA-049209F3EA8CQ36276649-A058B1EA-7447-4F48-87DC-2D9705A75169Q37116075-52901CC8-0623-409B-9C0C-423E83F9F7C2Q37389682-EA0655E0-CB29-44A4-955F-527DA7DCA6C4Q37942472-4F34F16D-D579-49E6-8C0B-322841D337D2Q38009230-B23994A2-E23F-4EDF-8EFF-46B788FC2B00Q38072598-FD16DEC1-FE42-4D56-866B-D4F62C0C59A5Q38110433-5DF45892-3D5B-4AC4-9DB5-79BCC2E90261Q38128342-816BBE53-A197-430C-AEF2-FCD67C3B4843Q38705177-A1C373BE-ECE1-46C2-97F2-32F528392AEBQ39810650-75E3E45D-87AC-4DE1-9A47-8DD7713D9C98Q39963734-991403E0-81E4-4475-94E8-C8C20324283DQ42257325-079460DE-CBC4-435A-A6F7-194EE318A133Q46186994-EE506455-010C-45AB-9208-D9514510EC2BQ47324299-B1D0F462-6554-4A64-88AF-023F901D7383Q50034109-79762975-2849-497E-8C1B-AD6CDBB26221Q51221582-89C1A606-CE3B-40E5-8BD8-00DCF47F9E83
P2860
Lymphatic transport of proteins after s.c. injection: implications of animal model selection.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Lymphatic transport of protein ...... ons of animal model selection.
@ast
Lymphatic transport of protein ...... ons of animal model selection.
@en
Lymphatic transport of protein ...... ons of animal model selection.
@nl
type
label
Lymphatic transport of protein ...... ons of animal model selection.
@ast
Lymphatic transport of protein ...... ons of animal model selection.
@en
Lymphatic transport of protein ...... ons of animal model selection.
@nl
prefLabel
Lymphatic transport of protein ...... ons of animal model selection.
@ast
Lymphatic transport of protein ...... ons of animal model selection.
@en
Lymphatic transport of protein ...... ons of animal model selection.
@nl
P1476
Lymphatic transport of protein ...... ions of animal model selection
@en
P2093
C J Porter
G A Edwards
P304
P356
10.1016/S0169-409X(01)00153-3
P407
P577
2001-08-01T00:00:00Z